GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $421,000 | +94.9% | 1,942 | +3.7% | 0.02% | +77.8% |
| Q4 2020 | $216,000 | -30.1% | 1,872 | -41.0% | 0.01% | -43.8% |
| Q3 2020 | $309,000 | -33.1% | 3,173 | -15.7% | 0.02% | -38.5% |
| Q2 2020 | $462,000 | +71.1% | 3,766 | +22.2% | 0.03% | +30.0% |
| Q1 2020 | $270,000 | -35.9% | 3,081 | -23.4% | 0.02% | +11.1% |
| Q4 2019 | $421,000 | -3.0% | 4,022 | +6.5% | 0.02% | -18.2% |
| Q3 2019 | $434,000 | -41.2% | 3,777 | -11.7% | 0.02% | -37.1% |
| Q2 2019 | $738,000 | +3.7% | 4,279 | +1.4% | 0.04% | +2.9% |
| Q1 2019 | $712,000 | +107.0% | 4,221 | +19.5% | 0.03% | +61.9% |
| Q4 2018 | $344,000 | – | 3,532 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |